Topic: Martin Shkreli

A federal appeals court on Tuesday upheld a lifetime ban on Martin Shkreli working in the pharmaceutical industry and ordered him to pay a multimillion-dollar disgorgement fine for illegally hiking drug prices.

The Federal Trade Commission wants a federal judge to hold Martin Shkreli in contempt for failing to provide the FTC information needed to determine whether his new company violates a ban on pharmaceutical work.

Former pharmaceutical CEO Martin Shkreli was released from a Pennsylvania prison early Wednesday after serving part of a seven-year sentence for fraud, the federal Bureau of Prisons confirmed.

A federal judge on Friday ordered former pharmaceutical CEO Martin Shkreli to pay $64.6 million for illegally ballooning the price of a drug to treat parasitic diseases.

A company once owned by hedge fund manager Martin Shkreli, a young investor who became known as "pharma bro," has agreed to pay $40 million to settle charges that it ran up the cost for a potentially life-saving drug.

The Justice Department on Tuesday announced it sold a one-of-a-kind Wu-Tang Clan album seized from former pharmaceutical CEO Martin Shkreli to clear an amount he owed for his conviction on charges of security fraud.

The Federal Trade Commission has charged disgraced former drug industry executive Martin Shkreli and Vyera Pharmaceuticals with concocting an elaborate competition-fixing scheme to maintain their monopoly over Daraprim.

A federal appeals court on Thursday refused to overturn the conviction of former pharmaceutical CEO Martin Shkreli, who's serving seven years in prison for fraud.

Pfizer agreed to pay $23.85 million to resolve claims it violated the False Claims Act.

Martin Shkreli, a former pharmaceutical executive convicted on three counts related to securities fraud, was ordered Friday to serve seven years in prison.